Back to Search
KIRRE HANNAN, PHARMD
PHARMD
Pharmacist
NPI: 1386278117Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
22521(IA)
Research & Publications (20)
mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF.
PMID 14612424·Mol Cell Biol·2003
7-preclinical
Troglitazone stimulates repair of the endothelium and inhibits neointimal formation in denuded rat aorta.
PMID 12663374·Arterioscler Thromb Vasc Biol·2003
7-preclinical
Activation of S6K1 (p70 ribosomal protein S6 kinase 1) requires an initial calcium-dependent priming event involving formation of a high-molecular-mass signalling complex.
PMID 12429015·Biochem J·2003
8-other
Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1.
PMID 11042686·Oncogene·2000
7-preclinical
RNA polymerase I transcription in confluent cells: Rb downregulates rDNA transcription during confluence-induced cell cycle arrest.
PMID 10918607·Oncogene·2000
7-preclinical
Phosphorylation regulates copper-responsive trafficking of the Menkes copper transporting P-type ATPase.
PMID 19576997·Int J Biochem Cell Biol·2009
7-preclinical
UBF levels determine the number of active ribosomal RNA genes in mammals.
PMID 19103806·J Cell Biol·2008
7-preclinical
Translational control of c-MYC by rapamycin promotes terminal myeloid differentiation.
PMID 18621930·Blood·2008
8-other
Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function.
PMID 18092230·Growth Factors·2007
6-review
A specific role for AKT3 in the genesis of ovarian cancer through modulation of G(2)-M phase transition.
PMID 17178867·Cancer Res·2006
8-other
MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation.
PMID 15282543·EMBO J·2004
7-preclinical
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).
PMID 14996598·Am J Cardiol·2004
3-trial
Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction.
PMID 14975462·J Am Coll Cardiol·2004
3-trial
Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial.
PMID 12706917·J Am Coll Cardiol·2003
3-trial
Protein kinase-dependent phosphorylation of the Menkes copper P-type ATPase.
PMID 12646208·Biochem Biophys Res Commun·2003
7-preclinical
Direct identification of tyrosine 474 as a regulatory phosphorylation site for the Akt protein kinase.
PMID 12149249·J Biol Chem·2002
7-preclinical
15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure.
PMID 12039996·J Am Soc Nephrol·2002
7-preclinical
Ro 31-6045, the inactive analogue of the protein kinase C inhibitor Ro 31-8220, blocks in vivo activation of p70(s6k)/p85(s6k): implications for the analysis of S6K signalling.
PMID 12023032·FEBS Lett·2002
7-preclinical
Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition.
PMID 11110770·Circ Res·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3421 W 9TH ST
WATERLOO, IA 50702 - Phone
- (319) 272-8800
Quick Facts
- NPI
- 1386278117
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile